109 related articles for article (PubMed ID: 31147194)
1. Occurrence, mortality and predictors of complicated cardiac perforation in patients with CRT-D: Based on the National Inpatient Sample registry.
Kawata H; Erande A; Lafi O; Chen CW; Hirai T; Santucci P; Malik S
Int J Cardiol; 2019 Oct; 293():109-114. PubMed ID: 31147194
[TBL] [Abstract][Full Text] [Related]
2. Frequency of in-hospital adverse outcomes and cost utilization associated with cardiac resynchronization therapy defibrillator implantation in the United States.
Patel N; Viles-Gonzalez J; Agnihotri K; Arora S; Patel NJ; Aneja E; Shah M; Badheka AO; Pothineni NV; Kancharla K; Mulpuru S; Noseworthy PA; Kusumoto F; Cha YM; Deshmukh AJ
J Cardiovasc Electrophysiol; 2018 Oct; 29(10):1425-1435. PubMed ID: 30016005
[TBL] [Abstract][Full Text] [Related]
3. Incidence and outcomes of cardiac tamponade in patients undergoing cardiac resynchronization therapy.
Adegbala O; Olagoke O; Adejumo A; Akintoye E; Oluwole A; Alebna P; Williams K; Lieberman R; Afonso L
Int J Cardiol; 2018 Dec; 272():137-141. PubMed ID: 30045818
[TBL] [Abstract][Full Text] [Related]
4. Device-related infective endocarditis in cardiac resynchronization therapy recipients - Single center registry with over 2500 person-years follow up.
Jędrzejczyk-Patej E; Mazurek M; Kowalski O; Sokal A; Kozieł M; Adamczyk K; Przybylska-Siedlecka K; Morawski S; Liberska A; Szulik M; Podolecki T; Kowalczyk J; Kalarus Z; Lenarczyk R
Int J Cardiol; 2017 Jan; 227():18-24. PubMed ID: 27846457
[TBL] [Abstract][Full Text] [Related]
5. Facility-Level Variation and Clinical Outcomes in Use of Cardiac Resynchronization Therapy With and Without an Implantable Cardioverter-Defibrillator.
Kramer DB; Normand ST; Volya R; Hatfield LA
Circ Cardiovasc Qual Outcomes; 2018 Dec; 11(12):e004763. PubMed ID: 30562069
[TBL] [Abstract][Full Text] [Related]
6. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF;
Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396
[TBL] [Abstract][Full Text] [Related]
7. Utilization and in-hospital complications of cardiac resynchronization therapy: trends in the United States from 2003 to 2013.
Hosseini SM; Moazzami K; Rozen G; Vaid J; Saleh A; Heist KE; Vangel M; Ruskin JN
Eur Heart J; 2017 Jul; 38(27):2122-2128. PubMed ID: 28329322
[TBL] [Abstract][Full Text] [Related]
8. The effect of weight loss on clinical outcomes in patients implanted with a cardiac resynchronization therapy device-A MADIT-CRT substudy.
Aktas MK; Zareba W; Huang DT; McNitt S; Polonsky S; Chen L; Stockburger M; Merkely B; Moss AJ; Kutyifa V
J Card Fail; 2014 Mar; 20(3):183-9. PubMed ID: 24361804
[TBL] [Abstract][Full Text] [Related]
9. Complications in recipients of cardioverter-defibrillator or cardiac resynchronization therapy: Insights from Silesian Center Defibrillator registry.
Tajstra M; Gadula-Gacek E; Kurek A; Adamowicz-Czoch E; Olszowski D; Ostręga M; Ciślak A; Pyka Ł; Hawranek M; Lekston A; Poloński L; Gąsior M
Cardiol J; 2017; 24(5):515-522. PubMed ID: 27734455
[TBL] [Abstract][Full Text] [Related]
10. Impact of atrial fibrillation on early complications and one year-survival after cardioverter defibrillator implantation: results from the German DEVICE registry.
Köbe J; Wasmer K; Andresen D; Kleemann T; Spitzer SG; Jehle J; Brachmann J; Stellbrink C; Hochadel M; Senges J; Klein HU; Eckardt L
Int J Cardiol; 2013 Oct; 168(4):4184-90. PubMed ID: 23948108
[TBL] [Abstract][Full Text] [Related]
11. Reduced long-term overall mortality in heart failure patients with prolonged QRS treated with CRT combined with ICD vs. heart failure patients with narrow QRS treated with ICD only.
Palmisano P; Accogli M; Pisanò EC; Zaccaria M; De Blasi S; Ponzetta MA; Valsecchi S; Milanese G; Lauretti M; Magliari F
Europace; 2016 Sep; 18(9):1374-82. PubMed ID: 26612878
[TBL] [Abstract][Full Text] [Related]
12. Coronary Venous Dissection from Left Ventricular Lead Placement During Cardiac Resynchronization Therapy With Defibrillator Implantation and Associated in-Hospital Adverse Events (from the NCDR ICD Registry).
Hsu JC; Varosy PD; Bao H; Dewland TA; Curtis JP; Marcus GM
Am J Cardiol; 2018 Jan; 121(1):55-61. PubMed ID: 29102348
[TBL] [Abstract][Full Text] [Related]
13. Impact of institutional procedural volume on inhospital outcomes after cardiac resynchronization therapy device implantation: US national database 2003-2011.
Yeo I; Kim LK; Lerman BB; Cheung JW
Heart Rhythm; 2017 Dec; 14(12):1826-1832. PubMed ID: 28917564
[TBL] [Abstract][Full Text] [Related]
14. Impact of haematoma after pacemaker and CRT device implantation on hospitalization costs, length of stay, and mortality: a population-based study.
Sridhar AR; Yarlagadda V; Yeruva MR; Kanmanthareddy A; Vallakati A; Dawn B; Lakkireddy D
Europace; 2015 Oct; 17(10):1548-54. PubMed ID: 25855676
[TBL] [Abstract][Full Text] [Related]
15. PR interval identifies clinical response in patients with non-left bundle branch block: a Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy substudy.
Kutyifa V; Stockburger M; Daubert JP; Holmqvist F; Olshansky B; Schuger C; Klein H; Goldenberg I; Brenyo A; McNitt S; Merkely B; Zareba W; Moss AJ
Circ Arrhythm Electrophysiol; 2014 Aug; 7(4):645-51. PubMed ID: 24963007
[TBL] [Abstract][Full Text] [Related]
16. Increased late complex device infections are determined by cardiac resynchronization therapy-defibrillator infection.
Unsworth JD; Zaidi A; Hargreaves MR
Europace; 2015 Nov; 17(11):1708-11. PubMed ID: 25883081
[TBL] [Abstract][Full Text] [Related]
17. Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT.
Perkiomaki JS; Ruwald AC; Kutyifa V; Ruwald MH; Mcnitt S; Polonsky B; Goldstein RE; Haigney MC; Krone RJ; Zareba W; Moss AJ;
Europace; 2015 Dec; 17(12):1816-22. PubMed ID: 26071234
[TBL] [Abstract][Full Text] [Related]
18. Cardiac perforation from implantable cardioverter-defibrillator lead placement: insights from the national cardiovascular data registry.
Hsu JC; Varosy PD; Bao H; Dewland TA; Curtis JP; Marcus GM
Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):582-90. PubMed ID: 24002030
[TBL] [Abstract][Full Text] [Related]
19. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
[TBL] [Abstract][Full Text] [Related]
20. Trends and outcomes of cardiac resynchronization therapy upgrade procedures: A comparative analysis using a United States National Database 2003-2013.
Cheung JW; Ip JE; Markowitz SM; Liu CF; Thomas G; Feldman DN; Swaminathan RV; Lerman BB; Kim LK
Heart Rhythm; 2017 Jul; 14(7):1043-1050. PubMed ID: 28214565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
